SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 32.53+5.9%2:21 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Olu Emuleomo who started this subject11/9/2002 1:05:04 PM
From: Robert K.  Read Replies (2) of 17367
 
Well bpi has been mentioned, how about the "defunct" mycoprex......So, like, they just stopped it?????
I personally do not believe it.
>XOMA Mycoprex™ Antifungal Products (MICROSOFT POWERPOINT) - CG 0667 1. Recombinant Human Bactericidal/Permeability-Increasing Protein (BPI): Potential Role in Acute Therapy of Bioterrorism Agents. ...
fda.gov
CBER - Medical Defense Against Bioterrorism - Workshop - Slide ... - ... Recombinant Human Bactericidal/Permeability-Increasing Protein (BPI): Potential Role in Acute Therapy of Bioterrorism Agents Patrick J. Scannon, MD, PhD XOMA ...
fda.gov
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext